<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">19469</article-id><article-id pub-id-type="doi">10.7554/eLife.19469</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Factors essential for L,D-transpeptidase-mediated peptidoglycan cross-linking and β-lactam resistance in <italic>Escherichia coli</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="author-60956"><name><surname>Hugonnet</surname><given-names>Jean-Emmanuel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-62483"><name><surname>Mengin-Lecreulx</surname><given-names>Dominique</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-62484"><name><surname>Monton</surname><given-names>Alejandro</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-29633"><name><surname>den Blaauwen</surname><given-names>Tanneke</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-62485"><name><surname>Carbonnelle</surname><given-names>Etienne</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-62486"><name><surname>Veckerlé</surname><given-names>Carole</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33168"><name><surname>Brun</surname><given-names>Yves</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-71956"><name><surname>van Nieuwenhze</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-62488"><name><surname>Bouchier</surname><given-names>Christiane</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-62489"><name><surname>Tu</surname><given-names>Kuyek</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-62490"><name><surname>Rice</surname><given-names>Louis B</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-62491"><name><surname>Arthur</surname><given-names>Michel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1007-636X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>INSERM, UMR_S 1138, Centre de Recherche des Cordeliers</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff2"><institution>Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ Paris-Sud, Université Paris-Saclay</institution>, <addr-line><named-content content-type="city">Gif-sur-Yvette</named-content></addr-line>, <country>France</country></aff><aff id="aff3"><institution content-type="dept">Bacterial Cell Biology and Physiology, Swammerdam Institute for Life Sciences</institution>, <institution>University of Amsterdam</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff4"><institution>Indiana University</institution>, <addr-line><named-content content-type="city">Indiana</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution>Institut Pasteur</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff6"><institution content-type="dept">Rhode Island Hospital</institution>, <institution>Brown University</institution>, <addr-line><named-content content-type="city">Providence</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-43200"><name><surname>Gilmore</surname><given-names>Michael S</given-names></name><role>Reviewing editor</role><aff><institution>Harvard Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>michel.arthur@crc.jussieu.fr</email> (MA);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>10</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e19469</elocation-id><history><date date-type="received"><day>08</day><month>07</month><year>2016</year></date><date date-type="accepted"><day>20</day><month>10</month><year>2016</year></date></history><permissions><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-19469-v1.pdf"/><abstract><p>The target of β-lactam antibiotics is the D,D-transpeptidase activity of penicillin-binding proteins (PBPs) for synthesis of 4→3 cross-links in the peptidoglycan of bacterial cell walls. Unusual 3→3 cross-links formed by L,D-transpeptidases were first detected in <italic>Escherichia coli</italic> more than four decades ago, however no phenotype has previously been associated with their synthesis. Here we show that production of the L,D-transpeptidase YcbB in combination with elevated synthesis of the (p)ppGpp alarmone by RelA lead to full bypass of the D,D-transpeptidase activity of PBPs and to broad-spectrum β-lactam resistance. Production of YcbB was therefore sufficient to switch the role of (p)ppGpp from antibiotic tolerance to high-level β-lactam resistance. This observation identifies a new mode of peptidoglycan polymerization in <italic>E. coli</italic> that relies on an unexpectedly small number of enzyme activities comprising the glycosyltransferase activity of class A PBP1b and the D,D-carboxypeptidase activity of DacA in addition to the L,D-transpeptidase activity of YcbB.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>E. coli</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>RO1 307 AI046626</award-id><principal-award-recipient><name><surname>Rice</surname><given-names>Louis B</given-names></name><name><surname>Arthur</surname><given-names>Michel</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Joint Program Initiative on Antimicrobial Research</institution></institution-wrap></funding-source><award-id>ZonMW project 60-60900-98-207</award-id><principal-award-recipient><name><surname>Monton</surname><given-names>Alejandro</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Joint Program Initiative on Antimicrobial Research</institution></institution-wrap></funding-source><award-id>NAPCLI</award-id><principal-award-recipient><name><surname>Hugonnet</surname><given-names>Jean-Emmanuel</given-names></name><name><surname>Monton</surname><given-names>Alejandro</given-names></name><name><surname>den Blaauwen</surname><given-names>Tanneke</given-names></name><name><surname>Arthur</surname><given-names>Michel</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM113172</award-id><principal-award-recipient><name><surname>van Nieuwenhze</surname><given-names>Michael</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="datasets"><title>Major datasets</title><p/><p>The following datasets were generated:</p><p><related-object content-type="generated-dataset" id="dataro1" source-id="http://dx.doi.org/10.5061/dryad.t5r8m" source-id-type="uri"><collab>Chrisitane Bouchier</collab>, <collab>Jean-Emmanuel Hugonnet</collab>, <collab>Michel Arthur</collab>, <year>2015</year><x>,</x> <source>Raw genomic sequences of mecillinam and resistant mutants of E. coli</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5061/dryad.t5r8m">http://dx.doi.org/10.5061/dryad.t5r8m</ext-link><x>,</x> <comment>Available at Dryad Digital Repository under a CC0 Public Domain Dedication</comment></related-object></p></sec></sec></back></article>